The FactMR study offers the futuristic overview of the pregnancy point of care testing market for the forecast period 2018-2028. The study opines that the market will grow at a healthy 4.5% CAGR during the assessment period. Pregnancy point of care testing market revenues reached US$ 1.2 billion in 2018, according to new study by research firm FactMR. Increasing need for rapid and accurate diagnostics with the emergence of advanced technologies is providing an impetus to the ongoing developments in the pregnancy point of care testing market. The study opines that the market will envisage nearly 5% y-o-y in 2019 over 2018, with growing adoption of innovative technologies likely to redefine future trends.
Manufacturers are capitalizing on the increasing ubiquity of smartphones by introducing next-generation pregnancy point of care testing devices that can be connected to smartphone applications, finds FactMR. Smartphone-based pregnancy point of care testing products are emerging as a promising alternative to traditional laboratory-based diagnostic testing practices. Leading manufacturers are launching innovating products with smartphone connectivity to cater to the end-users’ demand for easy-to-use at-home pregnancy test kits.
In addition, the study also finds that modern smartphone-based pregnancy point of care testing devices are reducing in size, cost, as well as complexity, and this is an important factor to boost growth of the pregnancy point of care testing market. A mounting number of small businesses are entering the pregnancy point of care testing markets in developing regions and launching innovative smartphone-based products at competitive prices to attract consumers in emerging economies. The study opines that increasing number of new players in the market and growing price gap between leading players and new entrants will influence growth of the global pregnancy point of care testing market in the coming decade.
Request For a Sample Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=3560
Demand for hCG Urine Test Kits will Continue to Grow
Human chorionic gonadotrophin (hCG) urine test kits accounted for nearly 43% revenue share of the global pregnancy point of care testing market in 2018, and the trend will prevail in the upcoming years, according to the Fact.MR study. The study attributes the rising demand for hCG urine test kits to the burgeoning sales of pregnancy test kits across the world. In 2018, pregnancy test kits accounted for more than half the revenue share in the pregnancy point of care testing market, and higher reliability and accuracy of hCG urine tests in pregnancy point of care testing is bolstering its share in the global market at a rapid pace.
North America Accounts for over 50% Revenue Share of the Market
In 2018, the pregnancy point of care testing market in North America was valued at US$ 648 million, according to Fact.MR. Growing prevalence of gynecological and fertility disorders, triggered by changing lifestyle, is leading to the increased adoption of pregnancy point of care testing products across the region.